← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2007Last known activity
Nov 10, 2025
Timeline
1990s
- Jun 1, 1999
Novavax— Founded
2010s
- Dec 2, 2013
Isconova AB— Acquired
Drugs by trial phase (29 distinct, 54 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (8 own, 1 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT07086222Lead sponsorPhase 4Nov 10, 2025
- NCT07079670Lead sponsorPhase 3Oct 16, 2025
- NCT06485752Lead sponsorPhase 2/Phase 3Dec 2, 2024
- NCT06482359Lead sponsorPhase 2/Phase 3Nov 1, 2024
- NCT06291857Lead sponsorPhase 3Oct 21, 2024
- NCT06633835Lead sponsorPhase 4Sep 20, 2024
- NCT06409663Lead sponsorPhase 2/Phase 3Aug 5, 2024
- NCT06065176CollaboratorPhase 4Nov 22, 2023
- NCT06027229CollaboratorPhase 2Nov 20, 2023
- NCT05925127Study directorPhase 2/Phase 3Oct 16, 2023
- NCT05925127Lead sponsorPhase 2/Phase 3Oct 16, 2023
- NCT05975060Lead sponsorPhase 2/Phase 3Sep 7, 2023
- NCT05975060Study directorPhase 2/Phase 3Sep 7, 2023
- NCT05973006Lead sponsorPhase 3Aug 16, 2023
- NCT05973006Study directorPhase 3Aug 16, 2023
Details
- Founded
- Gaithersburg, MD, US Jun 1, 1999
- Last known activity
- Nov 10, 2025